{"id":"W3085734793","doi":"10.25251/skin.4.supp.48","title":"Dupilumab Decreases Blood Biomarkers in Adolescents With Moderate-to-Severe Atopic Dermatitis: Data From a Phase 3 Trial (LIBERTY AD ADOL)","year":2020,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Sanofi Genzyme; Forskningsrådet om Hälsa, Arbetsliv och Välfärd; LEO Pharma; Galderma; Incyte; Pfizer Pharmaceuticals; Valeant Pharmaceuticals International; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Kyowa Hakko Kirin; Eli Lilly and Company","keywords":"Atopic dermatitis; Dupilumab; Medicine; Dermatology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007729064,0.0006061594,0.0008624722,0.0001450675,0.0001985084,0.0006108458,0.0002976444,0.0006119235,0.003467288],"category_scores_gemma":[0.0008222504,0.0001755551,0.001015005,0.0001710028,0.0002321397,0.0003449357,0.0001330754,0.001867639,0.0004491454],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003693133,"about_ca_system_score_gemma":0.000372664,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007485307,"about_ca_topic_score_gemma":0.002920044,"domain_scores_codex":[0.9997773,0.0001196548,0.00001165058,0.00002478854,0.00002530411,0.00004131032],"domain_scores_gemma":[0.9994054,0.0002269337,0.0001130753,0.00002455954,0.00004770131,0.000182453],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5963576,0.0108344,0.02111058,0.003828893,0.005740986,0.0003755137,0.0001777551,0.001227784,0.01754543,0.000314714,0.01662878,0.3258576],"study_design_scores_gemma":[0.6124119,0.2255954,0.1340041,0.00070974,0.004428208,0.001248045,0.000192201,0.002490067,0.005162908,0.0004501283,0.01323881,0.00006838048],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9616569,0.03032426,0.0003513537,0.001459663,0.0003582359,0.0005402001,0.001255148,0.0001241058,0.003930192],"genre_scores_gemma":[0.9870675,0.007375171,0.0008120498,0.001599819,0.000283812,0.0003240892,0.0009430117,0.00001331954,0.001581268],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003467288,"threshold_uncertainty_score":0.01159924,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02843055965295479,"score_gpt":0.2923379481617892,"score_spread":0.2639073885088344,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}